Reports & Presentations
Reports and Presentations
Financial reports
2021 Report and Financial Statements
2021 Full Year Results announcement
2020 Report and Financial Statements
2020 Full Year Results announcement
2019 Report and Financial Statements
Documents sent to shareholders
Result of General Meeting – 16 March 2023
Result of 2022 Annual General Meeting
Notice of 2022 Annual General Meeting
Result of General Meeting – 28 March 2022
Circular to Shareholders – 09 March 2022
Result of 2021 Annual General Meeting
Notice of 2021 Annual General Meeting
Result of General Meeting dated 26 November 2020
Circular to shareholders dated 10 November 2020
Result of 2020 Annual General Meeting
Presentations
Developing Novel Medicines that Prevent Serious Infections (March 2023)
R&D Investor Update meeting (18 October 2022)
2022 Interim results presentation (08 September 2022)
2021 Full Year results presentation (12 April 2022)
2021 Interim results presentation (09 September 2021)
2020 Full Year results presentation (14 April 2021)
Equity Development Webinar (31 March 2021)
Phase 2b Results Analyst and Investor Webcast (29 March 2021)
Phase 2b Results Presentation (29 March 2021)
Investor Presentation – February 2021